The Inquisitr |
FDA Gives Teva Go-Ahead on Asthma Drug
http://hamodia.com YERUSHALAYIM – The U.S. Food and Drug Administration (FDA) has announced approval of a new asthma treatment developed by the Israeli-based firm Teva, Globes reported on Sunday. CINQAIR injection for severe asthma sufferers is taken once every … FDA approves Cinqair to treat severe asthma Asthma Attacks Face Newly Approved Super Treatment 'Cinqair' Reslizumab (Cinqair) Approved to Treat Severe Asthma |
View full post on asthma – Google News